This chapter covers the general characteristics of the enzymes involved in glycan
biosynthesis and modification, including aspects of substrate specificity, primary
sequence relationships, structures, and enzyme mechanisms.
GENERAL PROPERTIES
FIGURE 5.1
.
Glycosylation reactions. A glycosyltransferase uses a glycosyl donor and an
acceptor substrate. In animals, glycosyl donors include nucleotide sugars
and dolichol-phosphate-linked monosaccharides and oligosaccharides. Bacteria
also use undecaprenyl-pyrophosphate (PP)-linked donors. Acceptors are most
commonly oligosaccharides, but (in rare cases) they can be monosaccharides.
Proteins and ceramides are also acceptors for the glycosyltransferases that
initiate glycoprotein, proteoglycan, and glycolipid synthesis. Many other
targets, such as drugs and other small molecules, can be glycosylated, but
these are not discussed in this chapter. Even DNA can be glycosylated.
The biosynthesis of glycans is primarily determined by the glycosyltransferases that
assemble monosaccharide moieties into linear and branched glycan chains. As might be
expected from the complex array of glycan structures found in nature, the
glycosyltransferases constitute a very large family of enzymes. However, they have
in common the ability to catalyze a group-transfer reaction in which the
monosaccharide moiety of a simple nucleotide sugar donor substrate (e.g., UDP-Gal,
GDP-Fuc, or CMP-Sia; see
Chapter 4) is
transferred to the acceptor substrate (). In some instances, the donor substrates are lipids, such as
dolichol-phosphate linked to mannose or glucose or a dolichol-oligosaccharide
precursor (see
Chapter 8). Lipid-linked
donor sugars (e.g., undecaprenyl-pyrophosphoryl-
N-acetylmuramic
acid-pentapeptide-
N-acetylglucosamine) are also used by
bacterial glycosyltransferases in the assembly of peptidoglycan, lipopolysaccharide,
and capsules (see
Chapter 20).
The glycosyltransferases that initiate the synthesis of glycoconjugates use acceptor
substrates that include oligosaccharides, monosaccharides, polypeptides, lipids,
small organic molecules, and even DNA. Only enzymes involved in the biosynthesis of
glycoproteins, proteoglycans, and glycolipids are discussed in this chapter. The
vast majority of these glycosyltransferases are responsible for elongating glycan
chains. Generally speaking, these enzymes act sequentially, so that the product of
one enzyme yields a preferred acceptor substrate for the subsequent action of
another. The end result is a linear and/or branched polymer composed of
monosaccharides linked to one another. In most cases, acceptor recognition does not
involve the underlying polypeptide or glycolipid substrate, but several notable
exceptions exist that are described below. Despite this finding, specific
glycosylation sites of many glycoproteins carry predictable glycan structures,
suggesting a complex mechanism for controlling composition.
FIGURE 5.2
.
Glycan-modifying enzymes. A variety of donors are used to modify glycans.
A few of the enzymes involved in the biosynthesis of glycans are glycosidases that
remove monosaccharides to form intermediates that are then acted on by
glycosyltransferases. Processing of this type is especially relevant in the
formation of N-glycans; in this case, the nascent glycoprotein glycan
Glc
3Man
9GlcNAc
2-Asn is sequentially trimmed by
glucosidases and mannosidases before potential modification by glycosyltransferases
that lead to complex and hybrid-type chains (see
Chapter 8). In addition, glycans can be modified in many other
ways, for example, by sulfotransferases, phosphotransferases,
O-acetyl-transferases,
O-methyltransferases,
pyruvyltransferases, and ethanolamine phosphate transferases, to mention just a few
().
GLYCOSYLTRANSFERASE SPECIFICITY
FIGURE 5.3
.
Strict acceptor substrate specificity of glycosyltransferases as exemplified
by the human B blood group α1–3
galactosyltransferase. The B transferase adds galactose in
α1–3 linkage to the H antigen
(top). This enzyme requires the
α1–2-linked fucose modification of the H antigen for
activity because the B transferase does not add to an unmodified type-2
precursor (middle), or precursors modified by sialyl
residues (bottom) or other monosaccharides (not shown).
(For the monosaccharide symbol code, see Figure 1.5, which is reproduced on the inside front cover.)
Symbol Key:

The specificity of glycosyltransferases, with respect to nucleotide sugar donor and
glycan acceptor, led early on to the concept that each glycosidic linkage is the
product of a single enzyme. This so-called “one enzyme–one
linkage” hypothesis was advanced by Saul Roseman and coworkers. The
human B blood group α1–3 galactosyltransferase provides an
excellent example of such specificity. This enzyme catalyzes a glycosylation
reaction in which galactose is added in α linkage to the C-3 hydroxyl
group of a galactose residue on the acceptor substrate (). However, the enzyme only acts on galactose
containing fucose in α1–2 linkage. Prior modification by
other monosaccharides, such as α2–6-linked sialic acid,
yields a glycan that is not a substrate ().
We now know that there are also instances in which more than one enzyme can use the
same acceptor to make the same linkage. The human fucosyltransferases
III–VII, for example, all attach fucose in α1–3
linkage to N-acetyllactosamine moieties on glycans (see Chapter 13). Other examples include
α2–3 sialyltransferases that act on galactose,
β1–4 galactosyltransferases that act on
N-acetylglucosamine, and the family of GlcNAc
3-O-sulfotransferases that participate in heparin/heparan sulfate
synthesis. In some rare cases, a single enzyme can catalyze more than one reaction.
Human fucosyltransferase III can attach fucose in either
α1–3 or α1–4 linkage, and an enzyme
called EXTL2 can attach either N-acetylgalactosamine or
N-acetylglucosamine in α linkage to glucuronic acid.
The β1–4 galactosyltransferase involved in
N-acetyllactosamine formation exhibits an unusual flexibility in
specificity. When β1-4 galactosyltransferase binds
α-lactalbumin (the complex is called lactose synthase), it switches its
acceptor specificity from N-acetylglucosamine to glucose, which
enables lactose synthesis during milk formation.
Finally, some glycosyltransferases (such as those that synthesize the backbones of
glycosaminoglycans) have two separate active sites, for example, one that catalyzes
the attachment of N-acetylglucosamine to glucuronic acid and
another that attaches glucuronic acid to N-acetylglucosamine (see
Chapters 15 and 16). However, the examples described
above are all exceptions to the generally strict donor, acceptor, and linkage
specificity exhibited by most glycosyltransferases, a property that serves to define
and limit the number and type of glycan structures observed in a given organism.
TABLE 5.1
| GlcNAc-β-Asn | Asn-X-Ser/Thr (X = any amino
acid except Pro) |
| Glc-β-Asn | Asn-X-Ser/Thr |
| GalNAc-α-Ser/Thr | repeat domains rich in Ser, Thr, Pro, Gly,
Ala in no special sequence |
| GlcNAc-α-Thr | Thr-rich domain near Pro residues |
| GlcNAc-β-Ser/Thr | Ser/Thr-rich domains near Pro, Val, Ala,
Gly |
| Man-α-Ser/Thr α | Ser/Thr-rich domains |
| Fuc-α-Ser/Thr | EGF modules (Cys-X-X-Gly-Gly-Thr/Ser-Cys)
TSR modules
(TrpX5CysX2-3Ser/ThrCysX2Gly) |
| Glc-β-Ser | EGF modules (Cys-X-Ser-X-Pro-Cys) |
| Xyl-β-Ser | Ser-Gly (in the vicinity of one or more
acidic residues) |
| Glc/GlcNAc-Thr | Rho: Thr-37; Ras, Rac; Cdc42: Thr-35 |
| Gal-Thr | Gly-X-Thr (X = Ala, Arg, Pro,
Hyp, Ser) (vent worm) |
| Gal-β-Hyl | collagen repeats (X-Hyl-Gly) |
| Ara-α-Hyp | repetitive Hyp-rich domains (e.g.,
Lys-Pro-Hyp-Hyp-Val) |
| GlcNAc-Hyp | Skp1: Hyp-143 |
| Glc-α-Tyr | glycogenin: Tyr-194 |
| GlcNAc-α-1-P-Ser | Ser-rich domains (e.g.,
Ala-Ser-Ser-Ala) |
| Man-α-1-P-Ser | Ser-rich repeat domains |
| Man-α-C-Trp | Trp-X-X-Trp |
| Man-6-P-ethanolamine-protein | GPI attached after cleavage of
carboxy-terminal peptide |
In contrast to those glycosyltransferases that elongate glycan chains, initiation of
the biosynthesis of glycoproteins and glycolipids requires glycosyltransferases that
attach saccharides to either a polypeptide side chain or a sphingolipid base. As
might be expected, these enzymes also show a high degree of specificity for their
substrates. Among the polypeptide glycosyltransferases, those that initiate the
biosynthesis of O-glycans typically transfer a specific monosaccharide to the side
chain of serine or threonine (see
Chapters
9 and
16). In contrast, N-linked
glycans are initiated by the action of oligosaccharyltransferase, an enzyme that
transfers the glycan Glc
3Man
9GlcNAc
2 to the side
chain of asparagine residues in the sequence motif Asn-X-Ser/Thr (where X can be any
amino acid except proline). For amino acid–consensus sequences or
glycosylation motifs used in the formation of glycopeptide bonds, see
Table 5.1. The glycosyltransferases that
initiate the synthesis of glycosphingolipids transfer a monosaccharide moiety to
what was originally a serine residue in the ceramide lipid precursor of
sphingolipids (see
Chapter 10). Because
different glycolipids have different ceramide moieties, it appears that some
glycosyltransferases, such as the sialyltransferases, differentially recognize their
substrates based on the nature of the ceramide moiety.
PROTEIN/GLYCOPROTEIN ACCEPTORS AND GLYCOSYLTRANSFERASE ACTION
Among the glycosyltransferases that use proteins/glycoproteins as acceptor
substrates, the underlying polypeptide chain of the acceptor is used in different
ways to confer specificity on the glycosylation reaction. As mentioned above, all
N-glycans are initiated by oligosaccharyltransferase, an enzyme that
cotranslationally transfers the N-glycan precursor to asparagine residues in the
sequence motif Asn-X-Ser/Thr. In contrast, many enzymes can glycosylate serine and
threonine residues leading to O-glycans possessing O-GlcNAc, O-GalNAc, O-fucose,
O-mannose, and O-xylose linkages. Among the enzymes responsible for these linkages,
specificity for a particular serine or threonine residue is achieved in different
ways. For example, O-xylosylation has an absolute requirement for a glycine residue
located amino terminally to the serine with nearby acidic residues on one or both
sides of the glycosylation site. Some polypeptide O-GalNAc transferases even possess
a lectin domain that serves to direct the glycosyltransferase to regions of
polypeptide already possessing glycan chains. In this way, regions of polypeptide
that have a high degree of carbohydrate substitution, typical of mucin structures,
can be synthesized.
FIGURE 5.4
.
Recognition site for glycoprotein hormone N-acetylgalactosaminyltransferase
on human chorionic gonadotropin. Ribbon diagram of a fragment (residues
34–58) of human chorionic gonadotropin (PDB [protein
data bank] ID 1hrp). The Pro40-Leu41-Arg42 tripeptide and
residues Lys44 and Lys45 correspond to residues essential for recognition by
glycoprotein hormone N-acetylgalactosaminyltransferase. Residues
Asn52-Val53-Thr54 correspond to the N-glycosylation sequence motif of the
N-glycan (at Asn52) modified by the glycoprotein hormone
N-acetylgalactosaminyltransferase. Only the chitobiose core
(GlcNAcβ1–4GlcNAc) of the acceptor N-glycan is
shown.
A few glycosyltransferases are specific for a particular protein type, and in these
cases recognition seems to be dependent on the final folded form of the protein
acceptor. The O-fucosyltransferases that act on polypeptides selectively modify
epidermal growth factor (EGF) or thrombospondin repeats (TSR), protein domains that
must be properly folded and disulfide-bonded to serve as acceptor substrates. The
glycoprotein hormone GalNAc transferase provides an interesting example in which
modification of an N-glycan is dependent on the presence of the sequence motif
Pro-X-Arg/Lys positioned several amino acids amino terminally to the N-glycan being
modified. The motif is typically followed closely by additional positively charged
residues. The X-ray crystal structure of the acceptor substrate, human chorionic
gonadotropin, shows that the Pro-X-Arg/Lys motif is at the beginning of a short
surface-exposed helix that also contains the additional positively charged residues
(). The
N-acetylgalactosamine residues transferred by the glycoprotein
hormone GalNAc transferase subsequently undergo a biologically important
4-O-sulfation reaction that, in the case of lutenizing hormone and
follicle-stimulating hormone, generates a determinant recognized by specific liver
clearance receptors (see
Chapter 31).
Additional examples are provided by the polysialyltransferases specific for neural
cell adhesion molecule (N-CAM) (see
Chapter
14) and by EXTL3, an N-acetylglucosaminyltransferase that adds GlcNAc in
α1–4 linkage to glucuronic acid in the first committed step
to heparan sulfate biosynthesis on proteoglycans (see
Chapter 16).
In a variation on this theme, GlcNAc-1-phosphotransferase is able to modify a family
of enzymes that are specifically destined for lysosomes (see Chapter 30). In this case, lysine
residues appropriately spaced and positioned relative to the N-glycan being modified
have been shown to be important determinants of acceptor specificity.
The ER resident glucosyltransferase (GGT) has an acceptor substrate specificity
unique among glycosyltransferases. It specifically reglucosylates N-glycans on
misfolded glycoproteins, rendering them substrates for the chaperones calnexin and
calreticulin (see Chapter 36). Its
ability to differentiate between misfolded and properly folded glycoproteins is a
critical component of the ER quality control machinery.
GLYCOSYLTRANSFERASE SEQUENCE FAMILIES AND FOLD TYPES
FIGURE 5.5
.
Sialyl motifs. Domain structure of a typical sialyltransferase, showing the
sialyl motifs shared by this family of enzymes. The sialyl L motif of
48–49 amino acids shares significant similarity among members
and may be up to 65% identical in amino acid sequence. The
sialyl S motif is smaller (~23 amino acids) and diverges more among members
of the family, with only two absolutely conserved residues. In both cases,
identical residues are indicated and residues showing similarity are denoted
by parentheses. (Asterisk) Position of a highly conserved
sequence H-X4-E. Additional conserved motifs may exist as
well.
Symbol Key:

The cloning and sequencing of more than 500 genomes has now shown that
glycosyltransferases are a very prevalent enzyme type, representing
1–2% of the genome. More than 30,000 glycosyltransferase
sequences are known across all kingdoms, and they comprise approximately 90
glycosyltransferase families defined by primary sequence analysis. These are
described in the
carbohydrate-
active
en
zymes (CAZy) database (see
Chapter 7). Although the absence of significant sequence similarity
between members of one family and another constitutes the basis for this
classification, short sequence motifs common to the members of more than one family
have been identified. These sequence elements are typically found among
glycosyltransferases with a given donor substrate specificity; the sialyl motifs
common to eukaryotic sialyltransferases are a good example (). Sequence motifs common to
galactosyltransferases, fucosyltransferases, and
N-acetylglu-cosaminyltransferases have also been identified. In
contrast, the so-called “DXD” motif (asp–any
residue–asp) is not associated with any particular substrate
specificity; rather, the motif is involved in metal ion binding and catalysis, and
it is discussed in more detail below.
FIGURE 5.6
.
Ribbon diagrams of representative GT-A and GT-B folds. The GT-A and -B
structures correspond to those of rabbit β1-2
N-acetylglucosaminyltransferase I (PDB ID 1foa) and T4
phage β-glucosyltransferase (PDB ID 1j39), respectively. In both
cases, bound nucleotide sugar donor substrate is shown in stick
representation.
Despite the large number of sequence families that have been defined, structural
analysis has shown that glycosyltransferases possess a limited number of fold types.
To date, structures for members of 29 of the 90 families have been determined by
X-ray crystallography, and of these all but a few possess what have been termed the
GT-A or GT-B folds (). The
catalytic domain of the GT-A-fold enzymes can be viewed as a single domain. The
first approximately 120 amino acids show similarity to a structural motif called the
Rossmann fold, which is found in proteins that bind nucleotides and are responsible
for binding the nucleotide sugar donor substrate. With only one exception, the GT-A
enzymes have been found to possess a DXD motif and are metal-ion-dependent
glycosyltransferases. The GT-B-fold enzymes possess two distinct domains separated
by a cleft that binds the acceptor. The carboxy-terminal domain is primarily
responsible for binding the nucleotide sugar donor substrate, but both domains
possess elements similar to those of the Rossmann fold. Unlike enzymes that contain
the GT-A fold, the GT-B glycosyltransferases are metal-ion independent and do not
possess a DXD motif.
CATALYTIC MECHANISMS
FIGURE 5.7
.
Schematic representation of (a) inverting and
(b) retaining catalytic mechanisms. (a)
SN2-like attack of the acceptor leads to inversion of
stereochemistry at C1. For a glycosidase reaction, R2 would correspond to a
proton and R1 would be the remainder of the glycan. A and B label general
acid and base groups in the catalytic site of the enzyme. For a
glycosyltransferase reaction, R2 would correspond to the remainder of the
acceptor substrate and R1 would typically be the nucleoside monophosphate or
diphosphate moiety of the donor substrate. (b) This
mechanism has only been established for glycosidases. Two successive
SN2-like reactions separated by a glycosyl-enzyme intermediate
lead to retention of the configuration at C1. R1 corresponds to the
remainder of the glycan and R2 to a proton.
FIGURE 5.8
.
Catalytic site of bovine β1–4 galactosyltransferase.
Composite figure shows selected residues/atoms of the superimposition of the
donor complex (PDB ID 1tw1) on the acceptor complex (PDB ID 1tw5). O4
designates the C4 hydroxyl group of the
GlcNAcβ1–4GlcNAc acceptor substrate positioned for
in-line SN2 attack (arrow) on C1 of the UDP-Gal
donor substrate. The base form of D318 serves to partially deprotonate the
C4 hydroxyl group rendering it a better nucleophile. The positively charged
Mg++ ion coordinates the two
phosphates of the UDP leaving group, promoting cleavage of the
C1-Pβ bond by stabilizing the additional negative
charge that develops on Pβ of the leaving group.
D252-V253-D254 corresponds to the DXD motif in bovine
β1–4 galactosyltransferase.
Glycosyltransferases catalyze their reactions with either inversion or retention of
stereochemistry at the anomeric carbon atom of the donor substrate (). For example,
β1–4 galactosyltransferase, an inverting
glycosyltransferase, transfers galactose from UDP-α-Gal (naturally
occurring nucleotide sugars, except for CMP-Sia and CMP-KDO
[3-deoxy-D-
manno-octulosonic acid], are
typically α linked) to generate a β1-4-linked
galactose-containing product. Inversion of stereochemistry follows from the fact
that the enzyme uses an S
N2 (
substitution
nucleophilic bimolecular) reaction mechanism where an acceptor
hydroxyl group attacks the anomeric carbon atom from one side and UDP leaves from
the other (). Typically, enzymes
of this type possess an aspartic acid or glutamic acid residue whose side chain
serves to partially deprotonate the incoming acceptor hydroxyl group, rendering it a
better nucleophile (as shown in
for the β1–4 galactosyltransferase). In addition, these
enzymes promote catalysis by features that help to promote leaving-group departure.
In the GT-A enzymes, a metal ion, bound by the DXD motif, is typically positioned to
interact with the diphosphate moiety. The positively charged metal ion serves to
electrostatically stabilize the additional negative charge that develops on the UDP
leaving group during bond breakage (). In the one GT-A enzyme that is not metalion dependent, positively
charged side chains stabilize the leaving group, a strategy also used by some of the
GT-B-fold enzymes.
Although the mechanism used by inverting glycosyltransferases is not well understood,
insight into how they might work is provided by our knowledge of glycosidase
mechanism. On the basis of much structural and enzyme kinetic analysis, it is well
established that inverting glycosidases proceed via a single S
N2
displacement mechanism (),
whereas retaining glycosidases use a double displacement mechanism involving a
covalent glycosyl-enzyme intermediate (). In the double displacement mechanism, an aspartic acid or glutamic
acid side chain in the active site makes the first attack and inversion, followed by
a second water-mediated attack (on the glycosyl-enzyme intermediate) and inversion,
to give overall retention of stereochemistry. In fact, using mechanism-based
inhibitors, the glycosyl-enzyme intermediate has been trapped and studied by X-ray
crystallography for a number of glycosidases. However, similar attempts to trap and
study glycosyltransferase reaction intermediates have not yet been successful. An
alternate mechanism, also proposed for glycogen phosphorylase, is that of the
so-called S
Ni mechanism. In this case, the incoming nucleophile attacks
from the same side as the leaving group, leading to retention of configuration.
Further work is required to establish whether glycosyltransferases use this
mechanism.
Despite similarities in the mechanisms and transition states used by glycosidases and
glycosyltransferases, small-molecule inhibitors of many glycosidases exist (see
Chapter 50), whereas there are
relatively few glycosyltransferase inhibitors. This probably reflects the fact that
many good enzyme inhibitors mimic the transition state, a relatively simple task in
the case of the glycosidase reaction where the acceptor substrate is a simple water
molecule. Simple high-affinity competitive inhibitors of substrate binding provide
another means of inhibiting an enzyme reaction (see Chapter 50).
KINETIC MECHANISMS
In addition to understanding the structure and catalytic mechanisms of
glycosyltransferases, there is much interest in understanding the kinetic
=mechanism. Many glycosyltransferases have been shown to possess a Bi Bi
sequential kinetic mechanism in which the donor substrate binds before the acceptor
substrate, and the glycosylated acceptor is released before the nucleoside
monosphosphate or disphosphate, depending on the reaction. Such kinetics are easily
explained by a structural model in which the active site represents a deep pocket,
with the nucleotide sugar substrate at the bottom and the acceptor substrate stacked
on top. If the acceptor substrate were to bind first, it would sterically preclude
donor substrate binding. Necessarily, release of the glycosylated product must
precede release of the nucleoside phosphate. Although largely consistent with such a
model, the X-ray crystal structures of glycosyltransferase-substrate complexes also
shows that substrate-dependent ordering of flexible loops is a feature common to
glycosyltransferases. Typically, donor substrate binding orders a loop(s) that in
turn facilitates acceptor substrate binding.
SULFATION AND OTHER MODIFICATIONS
Glycans can undergo a number of modifications, depending on the major subclass and
species of origin. The sulfotransferases are a large family of enzymes found in both
the cytoplasm and the Golgi. Enzymes from the cytoplasm sulfate low-molecular-weight
substrates such as steroids and exogenous compounds, whereas those from the Golgi
sulfate a large number of cell-surface and secreted glycans. Sulfotransferases have
a particularly important role in the production of glycosaminylglycans, molecules
involved in embryological development and physiology (see Chapters 16 and 24). They are also involved in the formation of L-selectin ligands, glycans
required for the trafficking of lymphocytes across high endothelial venules in lymph
nodes (see Chapter 31). All
sulfotransferases use 3′-phospho-adenosine-5′-phosphosulfate
(PAPS) as the sulfate donor (see Chapter
4). Although the sequence similarity among sulfotransferases can be very low,
they all possess conserved sequence motifs responsible for binding the
5′ and 3′ phosphate groups of PAPS. Moreover, structural
analysis has shown that all of the sulfotransferases solved to date possess the same
basic structure. Mechanistically, the enzyme proceeds via an SN2-like
reaction, with the hydroxyl group of the acceptor making an in-line attack on the
sulfate group. In conjunction with structural analysis, mutagenesis has provided
insight into the catalytic role played by a number of residues highly conserved
among the sulfotransferases. Of these, a histidine residue serves to activate the
hydroxyl nucleophile and a lysine assists in stabilizing the PAP leaving group.
Interestingly, a conserved serine seems to be involved in modulating the activity of
these enzymes to prevent PAPS hydrolysis in the absence of acceptor substrate.
Phosphorylation of sugar residues also occurs (e.g., at C-2 of xylose in
proteoglycans), but little is known about the nature of this reaction.
Phosphoglycosylation, a process in which a sugar phosphate is transferred from a
nucleotide sugar donor directly to a serine residue on a protein (e.g.,
GlcNAc-P-serine), occurs in Dictyostelium. Mannose-6-phosphate on
the N-glycans of lysosomal enzymes serves as a targeting signal. However, the
formation of this phosphate ester is not mediated by a typical ATP-using kinase, but
rather by a two-step reaction involving the donor UDP-GlcNAc (see Chapter 30). Detailed studies of reaction
mechanisms have not yet been undertaken.
O-Acetylation occurs in bacteria and in the modification of sialic acids, but little
information is available about the chemistry of these reactions. N-Deacetylation of
N-acetylglu-cosamine residues occurs during heparin/heparan
sulfate formation (see Chapter 16),
lipopolysaccharide assembly (see Chapter
20), and GPI-anchor synthesis (see Chapter 11). The bacterial enzyme is zinc dependent, but in-depth
studies of the vertebrate N-deacetylases have not been performed. N-Deacetylation of
N-acetylneuraminic acid (the most common sialic acid) has also
been reported (see Chapter 14).
Finally, glycans can be modified in many other ways, some of which are listed in
. These include pyruvylation
(e.g., in the formation of
N-acetylmuramic acid; see
Chapter 20), the addition of ethanolamine
phosphate (e.g., during GPI-anchor synthesis; see
Chapter 11), and alkylation, deoxygenation, and halogenation
in microbial glycans. All of these reactions are catalyzed by unique transferases or
oxidoreductases and represent areas of active research.
FURTHER READING
Manzella SM, Hooper LV, Baenziger JU.
Oligosaccharides containing β1,4-linked
N-acetyl-galactosamine, a paradigm for protein-specific glycosylation.
J. Biol. Chem.
1996; 271: 12117–12120.
[PubMed]
Negishi M, Pedersen LG, Petrotchenko E, Shevtsov S, Gorokhov A, Kakuta Y, Pedersen LC.
Structure and function of sulfotransferases.
Arch. Biochem. Biophys.
2001; 390: 149–157.
[PubMed]
Spiro RG. Protein glycosylation: Nature, distribution, enzymatic formation,
and disease implications of glycopeptide bonds.
Glycobiology.
2002; 12: 43R–56R.
Coutinho PM, Deleury E, Davies GJ, Henrissat B.
An evolving hierarchical family classification for
glycosyltransferases.
J. Mol. Biol.
2003; 328: 307–317.
[PubMed]
Negishi M, Dong J, Darden TA, Pedersen LG, Pedersen LC.
Glucosaminylglycan biosynthesis: What we can learn from the X-ray
crystal structures of glycosyltransferases GlcAT1 and EXTL2.
Biochem. Biophys. Res. Commun.
2003; 303: 393–398.
[PubMed]
Ten Hagen KG, Fritz TA, Tabak LA.
All in the family: The UDP-GalNAc:polypeptide
N-acetylgalactosaminyltransferases.
Glycobiology.
2003; 13: 1R–16R.
[PubMed]
Haltiwanger RS, Lowe JB.
Role of glycosylation in development.
Annu. Rev. Biochem.
2004; 73: 491–537.
[PubMed]
Lairson LL, Withers SG. Mechanistic analogies amongst carbohydrate modifying enzymes.
Chem. Commun.
2004; 20: 2243–2248.
Davies GJ, Gloster TM, Henrissat B.
Recent structural insights into the expanding world of
carbohydrate-active enzymes.
Curr. Opin. Struct. Biol.
2005; 15: 637–645.
[PubMed]
Jones J, Krag SS, Betenbaugh MJ.
Controlling N-linked glycan site occupancy.
Biochim Biophys Acta.
2005; 1726: 121–137.
[PubMed]
Qasba PK, Ramakrishnan B, Boeggeman E.
Substrate-induced conformational changes in glycosyltransferases.
Trends Biochem. Sci.
2005; 30: 53–62.
[PubMed]
Blanchard S, Thorson JS.
Enzymatic tools for engineering natural product glycosylation.
Curr. Opin. Chem. Biol.
2006; 10: 263–271.
[PubMed]
Letts JA, Rose NL, Fang YR, Barry CH, Borisova SN, Seto NOL, Palcic MM, Evans SV.
Differential recognition of the Type I and II H antigen acceptors
by the human ABO(H) blood group A and B glycosyltransferases.
J. Biol. Chem.
2006; 281: 3625–3632.
[PubMed]
Luo Y, Nita-Lazar A, Haltiwanger RS.
Two distinct pathways for O-fucosylation of epidermal growth
factor-like or thrombospondin type 1 repeats.
J. Biol. Chem.
2006; 281: 9385–9392.
[PubMed]
Narimatsu H.
Human glycogene cloning: Focus on
β3-glycosyltransferase and β4-glycosyltrans-ferase
families.
Curr. Opin. Struct. Biol.
2006; 16: 567–575.
[PubMed]
Yu H, Chen X.
Carbohydrate post-glycosylational modifications.
Org. Biomol. Chem.
2007; 5: 865–872.
[PubMed]
Copyright ©2009 by The Consortium of Glycobiology Editors, La Jolla,
California
ǀ